share_log

Redhill Biopharma analyst ratings

Redhill Biopharma analyst ratings

Redhill Biophma分析师评级
Benzinga Analyst Ratings ·  2021/09/15 06:06
Date Research Firm Action Current PT
9/15/21 HC Wainwright & Co. Maintains Buy 21.0
8/31/21 Cantor Fitzgerald Initiates Coverage On Overweight 22.0
5/28/21 WBB Securities Downgrades Buy 16.0
5/18/21 HC Wainwright & Co. Initiates Coverage On Buy 23.0
9/11/20 BTIG Initiates Coverage On Buy 26.0
3/05/20 HC Wainwright & Co. Reiterates Buy 14.0
7/12/19 WBB Securities Upgrades Strong Buy 17.0
3/12/19 WBB Securities Upgrades Buy 17.0
6/25/18 Ladenburg Thalmann Initiates Coverage On Buy 20.0
1/26/18 Nomura Initiates Coverage On Buy 18.0
日期 研究公司 动作 当前 PT
9/15/21 HC Wainwright&Co. 维护 21.0
8/31/21 康托·菲茨杰拉德 在以下项目上启动覆盖范围 超重 22.0
5/28/21 WBB证券 降级 16.0
5/18/21 HC Wainwright&Co. 在以下项目上启动覆盖范围 23.0
9/11/20 BTIG 在以下项目上启动覆盖范围 26.0
3/05/20 HC Wainwright&Co. 重申 14.0
7/12/19 WBB证券 升级 大买特买 17.0
3/12/19 WBB证券 升级 17.0
6/25/18 拉登堡·塔尔曼 在以下项目上启动覆盖范围 20.0
1/26/18 野村 在以下项目上启动覆盖范围 18.0
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发